227 related articles for article (PubMed ID: 33971465)
1. Smac mimetics and TRAIL cooperate to induce MLKL-dependent necroptosis in Burkitt's lymphoma cell lines.
Koch A; Jeiler B; Roedig J; van Wijk SJL; Dolgikh N; Fulda S
Neoplasia; 2021 May; 23(5):539-550. PubMed ID: 33971465
[TBL] [Abstract][Full Text] [Related]
2. Smac mimetics and type II interferon synergistically induce necroptosis in various cancer cell lines.
Cekay MJ; Roesler S; Frank T; Knuth AK; Eckhardt I; Fulda S
Cancer Lett; 2017 Dec; 410():228-237. PubMed ID: 28923396
[TBL] [Abstract][Full Text] [Related]
3. A Bak-dependent mitochondrial amplification step contributes to Smac mimetic/glucocorticoid-induced necroptosis.
Rohde K; Kleinesudeik L; Roesler S; Löwe O; Heidler J; Schröder K; Wittig I; Dröse S; Fulda S
Cell Death Differ; 2017 Jan; 24(1):83-97. PubMed ID: 27834956
[TBL] [Abstract][Full Text] [Related]
4. Cotreatment with Smac mimetics and demethylating agents induces both apoptotic and necroptotic cell death pathways in acute lymphoblastic leukemia cells.
Gerges S; Rohde K; Fulda S
Cancer Lett; 2016 May; 375(1):127-132. PubMed ID: 26944210
[TBL] [Abstract][Full Text] [Related]
5. Smac mimetic triggers necroptosis in pancreatic carcinoma cells when caspase activation is blocked.
Hannes S; Abhari BA; Fulda S
Cancer Lett; 2016 Sep; 380(1):31-8. PubMed ID: 27267809
[TBL] [Abstract][Full Text] [Related]
6. Smac mimetics can provoke lytic cell death that is neither apoptotic nor necroptotic.
Miles MA; Caruso S; Baxter AA; Poon IKH; Hawkins CJ
Apoptosis; 2020 Aug; 25(7-8):500-518. PubMed ID: 32440848
[TBL] [Abstract][Full Text] [Related]
7. Identification of a synergistic combination of Smac mimetic and Bortezomib to trigger cell death in B-cell non-Hodgkin lymphoma cells.
Bhatti IA; Abhari BA; Fulda S
Cancer Lett; 2017 Oct; 405():63-72. PubMed ID: 28716527
[TBL] [Abstract][Full Text] [Related]
8. Key necroptotic proteins are required for Smac mimetic-mediated sensitization of cholangiocarcinoma cells to TNF-α and chemotherapeutic gemcitabine-induced necroptosis.
Akara-Amornthum P; Lomphithak T; Choksi S; Tohtong R; Jitkaew S
PLoS One; 2020; 15(1):e0227454. PubMed ID: 31914150
[TBL] [Abstract][Full Text] [Related]
9. The Smac mimetic BV6 cooperates with STING to induce necroptosis in apoptosis-resistant pancreatic carcinoma cells.
Hannes S; Karlowitz R; van Wijk SJL
Cell Death Dis; 2021 Aug; 12(9):816. PubMed ID: 34462421
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic targeting of necroptosis by Smac mimetic bypasses apoptosis resistance in acute myeloid leukemia cells.
Safferthal C; Rohde K; Fulda S
Oncogene; 2017 Mar; 36(11):1487-1502. PubMed ID: 27869161
[TBL] [Abstract][Full Text] [Related]
11. Beclin 1 functions as a negative modulator of MLKL oligomerisation by integrating into the necrosome complex.
Seo J; Seong D; Nam YW; Hwang CH; Lee SR; Lee CS; Jin Y; Lee HW; Oh DB; Vandenabeele P; Song J
Cell Death Differ; 2020 Nov; 27(11):3065-3081. PubMed ID: 32457484
[TBL] [Abstract][Full Text] [Related]
12. Smac mimetic and demethylating agents synergistically trigger cell death in acute myeloid leukemia cells and overcome apoptosis resistance by inducing necroptosis.
Steinhart L; Belz K; Fulda S
Cell Death Dis; 2013 Sep; 4(9):e802. PubMed ID: 24030154
[TBL] [Abstract][Full Text] [Related]
13. Proteasome inhibitors and Smac mimetics cooperate to induce cell death in diffuse large B-cell lymphoma by stabilizing NOXA and triggering mitochondrial apoptosis.
Dietz A; Dalda N; Zielke S; Dittmann J; van Wijk SJL; Vogler M; Fulda S
Int J Cancer; 2020 Sep; 147(5):1485-1498. PubMed ID: 32170726
[TBL] [Abstract][Full Text] [Related]
14. Receptor-interacting protein kinase 1 is a key mediator in TLR3 ligand and Smac mimetic-induced cell death and suppresses TLR3 ligand-promoted invasion in cholangiocarcinoma.
Lomphithak T; Choksi S; Mutirangura A; Tohtong R; Tencomnao T; Usubuchi H; Unno M; Sasano H; Jitkaew S
Cell Commun Signal; 2020 Oct; 18(1):161. PubMed ID: 33036630
[TBL] [Abstract][Full Text] [Related]
15. Smac mimetic primes apoptosis-resistant acute myeloid leukaemia cells for cytarabine-induced cell death by triggering necroptosis.
Chromik J; Safferthal C; Serve H; Fulda S
Cancer Lett; 2014 Mar; 344(1):101-109. PubMed ID: 24184825
[TBL] [Abstract][Full Text] [Related]
16. Potential mechanism of resistance to TRAIL-induced apoptosis in Burkitt's lymphoma.
Tafuku S; Matsuda T; Kawakami H; Tomita M; Yagita H; Mori N
Eur J Haematol; 2006 Jan; 76(1):64-74. PubMed ID: 16343273
[TBL] [Abstract][Full Text] [Related]
17. Identification of a novel synergistic induction of cell death by Smac mimetic and HDAC inhibitors in acute myeloid leukemia cells.
Steinwascher S; Nugues AL; Schoeneberger H; Fulda S
Cancer Lett; 2015 Sep; 366(1):32-43. PubMed ID: 26028172
[TBL] [Abstract][Full Text] [Related]
18. Regulation of tumour necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis in Burkitt's lymphoma cell lines.
Mouzakiti A; Packham G
Br J Haematol; 2003 Jul; 122(1):61-9. PubMed ID: 12823346
[TBL] [Abstract][Full Text] [Related]
19. T and B leukemic cell lines exhibit different requirements for cell death: correlation between caspase activation, DFF40/DFF45 expression, DNA fragmentation and apoptosis in T cell lines but not in Burkitt's lymphoma.
Luciano F; Ricci JE; Herrant M; Bertolotto C; Mari B; Cousin JL; Auberger P
Leukemia; 2002 Apr; 16(4):700-7. PubMed ID: 11960352
[TBL] [Abstract][Full Text] [Related]
20. [The cloning of human Smac gene and its pro-apoptotic effect on Burkitt's lymphoma cells].
Lu C; Wu SH; Chen JQ; Zhao F; Chi X; Pan XQ; Fei L; Guo M; Huang SM; Guo XR; Chen RH
Zhonghua Er Ke Za Zhi; 2005 Jul; 43(7):503-6. PubMed ID: 16083549
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
